Pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015, please find enclosed the media release for issued by the Company regarding business diversification.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Limited has announced its entry into the diagnostic testing, home sample collection, and teleconsultation segment, expanding beyond its existing primary healthcare, wellness, nutraceuticals, and herbal products businesses. Services will be offered through a dedicated website and mobile app, covering lab tests, home sample pickups, video doctor consultations, and digital access to reports and prescriptions. The company is targeting India's diagnostics market, which it pegs at Rs. 1.11 lakh crore and growing at 14% CAGR, with home sample collection expected to contribute 25–30% of this share. The move is aimed at building a vertically integrated preventive healthcare ecosystem and tapping into growing demand for affordable, doorstep health services.
This diversification opens a new, high-growth revenue stream for shareholders and reduces reliance on the company's traditional wellness and nutraceuticals business. The stock could see short-term positive sentiment, though execution risk and competition in the diagnostics space remain key factors to watch.